Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

Sternberg, C. N., Saad, F., Graff, J. N., Peer, A., Vaishampayan, U. N., Leung, E., Rosenbaum, E., Gurney, H., Epstein, R. J., Davis, I. D., Wu, B., Trandafir, L., Wagner, V. J. & Hussain, M., Feb 2020, In : Annals of Oncology. 31, 2, p. 257-265 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation

Ellis, R. J., Del Vecchio, S. J., Gallagher, K. M. J., Aliano, D. N., Barber, N., Bolton, D. M., Chew, E. T. S., Coombes, J. S., Coory, M. D., Davis, I. D., Donaldson, J. F., Francis, R. S., Giles, G. G., Gobe, G. C., Hawley, C. M., Johnson, D. W., Laird, A., Leung, S., Malki, M., Marco, D. J. T. & 8 others, McNeill, A. S., Neale, R. E., Ng, K. L., Phipps, S., Stewart, G. D., White, V. M., Wood, S. T. & Jordan, S. J., May 2020, In : Journal of the American Society of Nephrology : JASN. 31, 5, p. 1107-1117 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Galsky, M. D., Arija, J. Á. A., Bamias, A., Davis, I. D., De Santis, M., Kikuchi, E., Garcia-del-Muro, X., De Giorgi, U., Mencinger, M., Izumi, K., Panni, S., Gumus, M., Özgüroğlu, M., Kalebasty, A. R., Park, S. H., Alekseev, B., Schutz, F. A., Li, J. R., Ye, D., Vogelzang, N. J. & 7 others, Bernhard, S., Tayama, D., Mariathasan, S., Mecke, A., Thåström, A. C., Grande, E. & for the IMvigor130 Study Group, 16 May 2020, In : The Lancet. 395, 10236, p. 1547-1557 11 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Prizes

Australian Postgraduate Award

Rose Crossin (Recipient), 2015

Prize: Competitive Fellowships

Best Oral Presentation

Rose Crossin (Recipient), 2017

Prize: Prize (including medals and awards)

Best Oral Presentation

Rose Crossin (Recipient), 2016

Prize: Prize (including medals and awards)

Press / Media

Pregabalin misuse

Rose Crossin

27/11/18

1 item of Media coverage

Press/Media: Article/Feature

The effects of inhalant abuse during adolescence on growth

Rose Crossin

15/06/17

1 Media contribution

Press/Media: Expert Comment